Related Experiment Videos
Association between hypertension and risk of respiratory failure and mortality in patients with COVID-19: a
Xiaoqing Hu1, Kailong Ye1, Bifang Miao1
1Department of Respiratory Medicine, Mindong Hospital Affiliated to Fujian Medical University, Ningde, China.
Background:
Hypertension is highly prevalent among patients with Coronavirus Disease 2019 (COVID-19), yet its impact on respiratory failure and mortality remains controversial. Our objective was to evaluate the association between hypertension and adverse outcomes in COVID-19 patients and to develop predictive models for risk stratification.
Objective:
To investigate the association between hypertension and respiratory failure or mortality in patients with COVID-19: mediation analysis of laboratory biomarkers and development of a risk prediction model for adverse outcomes in hypertensive individuals with COVID-19.
Methods:
We retrospectively analyzed clinical data from hospitalized COVID-19 patients. After 1:1 propensity score matching (PSM) of hypertensive and non-hypertensive patients, multivariable logistic regression assessed hypertension's independent association with respiratory failure and in-hospital mortality. Mediation and subgroup analyses explored biomarker mediators and effect modifiers. Least Absolute Shrinkage and Selection Operator (A LASSO)-selected risk prediction model was validated by Area Under the ROC Curve (ROC-AUC) analysis.
Results:
Multivariable logistic regression showed that hypertension was independently associated with increased risks of respiratory failure (OR = 2.196, 95% CI: 1.170-4.120; P = 0.014) and in-hospital mortality (OR = 2.945, 95% CI: 1.420-6.107; P = 0.004). Mediation analysis revealed that eosinophil count and Estimated Glomerular Filtration Rate (eGFR) partially mediated these associations: for respiratory failure, they accounted for 44.5 and 15.6% of the total effect, respectively; for mortality, 50.0 and 16.7%. LASSO-based prediction models demonstrated an AUC of 0.788 for respiratory failure (using neutrophil count, C-Reactive Protein (CRP), Blood Urea Nitrogen (BUN), and albumin) and 0.694 for mortality (using neutrophil count and BUN).
Conclusion:
Compared with non-hypertensive COVID-19 patients, those with hypertension had significantly higher risks of respiratory failure and in-hospital mortality. Eosinophil count and eGFR significantly mediated these associations. A multi-marker model-combining neutrophil count, CRP, BUN, and albumin-showed good predictive performance for respiratory failure, supporting early risk identification and precision clinical decision-making.
Related Concept Videos
01:21Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:30Acute Respiratory Failure-III
01:21Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:19Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...